July 28, 2021
Medication nonadherence is widely recognized as a common and costly problem. Approximately 30% to 50% of US adults are not adherent to long-term medications leading to an estimated $100 billion in preventable costs annually. The barriers to medication adherence are similar to other complex health behaviors, such as weight loss, which have multiple contributing factors. Despite the widespread prevalence and cost of medication nonadherence, it is undetected and undertreated in a significant proportion of adults across care settings. According to the World Health Organization, “increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.” How can adherence be improved? We propose that the first step is to view medication nonadherence as a diagnosable and treatable medical condition. We believe technology must be leveraged properly to impact this healthcare crisis.
The RxSafe team has pharmacy owners at the front lines. Here's an interview with a Community Pharmacy Champion.
Special Guest Matthew Massey
Matthew Massey
Massey Drugs Inc
President/CEO
matthew@masseydrugs.com
Since opening its doors, Massey Drugs has been committed to helping the residents of the Shoals take care of what matters most- their health. Massey's friendly team of dedicated pharmacists, pharmacy technicians, and sales staff are there to make sure you get your medicines on your schedule so that you can live better.
RxSafe believes in a partnership approach to pharmacy automation. We’ve listened to retail and outpatient pharmacies voice their needs and concerns to improve patient safety and patient health outcomes while reducing DIR fees. Our response? Innovative technology solutions designed to accelerate your pharmacy’s success.
– Patents & Trademarks
– Privacy policy
– Term of Use